Access to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politics

dc.creatorKavanagh, Matthew M.
dc.creatorErondu, Ngozi A.
dc.creatorTomori, Oyewale
dc.creatorDzau, Victor J.
dc.creatorOkiro, Emelda A.
dc.creatorMaleche, Allan
dc.creatorAniebo, Ifeyinwa C.
dc.creatorRugege, Umunya
dc.creatorHolmes, Charles B.
dc.creatorGostin, Lawrence O.
dc.date.accessioned2020-08-06T21:13:09Z
dc.date.available2020-08-06T21:13:09Z
dc.date.created2020-05-30
dc.description.abstractenglishCoronavirus disease 2019 (COVID-19) has revealed how strikingly unprepared the world is for a pandemic and how easily viruses spread in our interconnected world. A governance crisis is unfolding alongside the pandemic as health officials around the world compete for access to scarce medical supplies. As governments of African countries, and those in low-income and middle-income countries around the world, seek to avoid potentially catastrophic epidemics and learn from what has worked in other countries, testing and other medical resources are of concern. With accelerating spread, funding is urgently needed. Yet even where there is enough money, many African health authorities are unable to obtain the supplies needed as geopolitically powerful countries mobilise economic, political, and strategic power to procure stocks for their populations.1, 2 We have seen this before. In the AIDS pandemic lifesaving diagnostics and drugs came to many African countries long after they were available in Europe and North America. In 2020, this situation can be avoided. Although health system weakness remains acute in many places, investments by national governments, the African Union, and international initiatives to tackle AIDS, tuberculosis, malaria, polio, and post-Ebola global health security have built important public health capacities. Global leaders have an ethical obligation to avoid needless loss of life due to the foreseeable prospect of slow and inadequate access to supplies in Africa.spa
dc.format.extent4 páginasspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.doihttps://doi.org/10.1016/S0140-6736(20)31093-Xspa
dc.identifier.issn0140-6736spa
dc.identifier.otherhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31093-X/fulltextspa
dc.identifier.urihttps://hdl.handle.net/20.500.12010/11719
dc.publisherThe Lancetspa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.localAbierto (Texto Completo)spa
dc.sourcereponame:Expeditio Repositorio Institucional UJTLspa
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozanospa
dc.subjectRecursos médicosspa
dc.subject.keywordMedical resourcesspa
dc.subject.lembSíndrome respiratorio agudo gravespa
dc.subject.lembCOVID-19spa
dc.subject.lembSARS-CoV-2spa
dc.subject.lembCoronavirusspa
dc.titleAccess to lifesaving medical resources for African countries: COVID-19 testing and response, ethics, and politicsspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localArtículospa

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
Access-to-lifesaving-medical-resources-for-African-countries--COV_2020_The-L.pdf
Tamaño:
80.69 KB
Formato:
Adobe Portable Document Format
Descripción:
Documento reservado

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
2.87 KB
Formato:
Item-specific license agreed upon to submission
Descripción: